1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologic Medication in COVID-19 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Neutralizing Antibodies
1.2.3 Anti-inflammatory Drugs
1.3 Market by Application
1.3.1 Global Biologic Medication in COVID-19 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 COVID-19
1.3.3 Influenza
1.3.4 Malaria
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biologic Medication in COVID-19 Market Perspective (2017-2028)
2.2 Biologic Medication in COVID-19 Growth Trends by Region
2.2.1 Biologic Medication in COVID-19 Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Biologic Medication in COVID-19 Historic Market Size by Region (2017-2022)
2.2.3 Biologic Medication in COVID-19 Forecasted Market Size by Region (2023-2028)
2.3 Biologic Medication in COVID-19 Market Dynamics
2.3.1 Biologic Medication in COVID-19 Industry Trends
2.3.2 Biologic Medication in COVID-19 Market Drivers
2.3.3 Biologic Medication in COVID-19 Market Challenges
2.3.4 Biologic Medication in COVID-19 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologic Medication in COVID-19 Players by Revenue
3.1.1 Global Top Biologic Medication in COVID-19 Players by Revenue (2017-2022)
3.1.2 Global Biologic Medication in COVID-19 Revenue Market Share by Players (2017-2022)
3.2 Global Biologic Medication in COVID-19 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biologic Medication in COVID-19 Revenue
3.4 Global Biologic Medication in COVID-19 Market Concentration Ratio
3.4.1 Global Biologic Medication in COVID-19 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologic Medication in COVID-19 Revenue in 2021
3.5 Biologic Medication in COVID-19 Key Players Head office and Area Served
3.6 Key Players Biologic Medication in COVID-19 Product Solution and Service
3.7 Date of Enter into Biologic Medication in COVID-19 Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologic Medication in COVID-19 Breakdown Data by Type
4.1 Global Biologic Medication in COVID-19 Historic Market Size by Type (2017-2022)
4.2 Global Biologic Medication in COVID-19 Forecasted Market Size by Type (2023-2028)
5 Biologic Medication in COVID-19 Breakdown Data by Application
5.1 Global Biologic Medication in COVID-19 Historic Market Size by Application (2017-2022)
5.2 Global Biologic Medication in COVID-19 Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Biologic Medication in COVID-19 Market Size (2017-2028)
6.2 North America Biologic Medication in COVID-19 Market Size by Type
6.2.1 North America Biologic Medication in COVID-19 Market Size by Type (2017-2022)
6.2.2 North America Biologic Medication in COVID-19 Market Size by Type (2023-2028)
6.2.3 North America Biologic Medication in COVID-19 Market Share by Type (2017-2028)
6.3 North America Biologic Medication in COVID-19 Market Size by Application
6.3.1 North America Biologic Medication in COVID-19 Market Size by Application (2017-2022)
6.3.2 North America Biologic Medication in COVID-19 Market Size by Application (2023-2028)
6.3.3 North America Biologic Medication in COVID-19 Market Share by Application (2017-2028)
6.4 North America Biologic Medication in COVID-19 Market Size by Country
6.4.1 North America Biologic Medication in COVID-19 Market Size by Country (2017-2022)
6.4.2 North America Biologic Medication in COVID-19 Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Biologic Medication in COVID-19 Market Size (2017-2028)
7.2 Europe Biologic Medication in COVID-19 Market Size by Type
7.2.1 Europe Biologic Medication in COVID-19 Market Size by Type (2017-2022)
7.2.2 Europe Biologic Medication in COVID-19 Market Size by Type (2023-2028)
7.2.3 Europe Biologic Medication in COVID-19 Market Share by Type (2017-2028)
7.3 Europe Biologic Medication in COVID-19 Market Size by Application
7.3.1 Europe Biologic Medication in COVID-19 Market Size by Application (2017-2022)
7.3.2 Europe Biologic Medication in COVID-19 Market Size by Application (2023-2028)
7.3.3 Europe Biologic Medication in COVID-19 Market Share by Application (2017-2028)
7.4 Europe Biologic Medication in COVID-19 Market Size by Country
7.4.1 Europe Biologic Medication in COVID-19 Market Size by Country (2017-2022)
7.4.2 Europe Biologic Medication in COVID-19 Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biologic Medication in COVID-19 Market Size (2017-2028)
8.2 Asia-Pacific Biologic Medication in COVID-19 Market Size by Type
8.2.1 Asia-Pacific Biologic Medication in COVID-19 Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Biologic Medication in COVID-19 Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Biologic Medication in COVID-19 Market Share by Type (2017-2028)
8.3 Asia-Pacific Biologic Medication in COVID-19 Market Size by Application
8.3.1 Asia-Pacific Biologic Medication in COVID-19 Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Biologic Medication in COVID-19 Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Biologic Medication in COVID-19 Market Share by Application (2017-2028)
8.4 Asia-Pacific Biologic Medication in COVID-19 Market Size by Region
8.4.1 Asia-Pacific Biologic Medication in COVID-19 Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Biologic Medication in COVID-19 Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biologic Medication in COVID-19 Market Size (2017-2028)
9.2 Latin America Biologic Medication in COVID-19 Market Size by Type
9.2.1 Latin America Biologic Medication in COVID-19 Market Size by Type (2017-2022)
9.2.2 Latin America Biologic Medication in COVID-19 Market Size by Type (2023-2028)
9.2.3 Latin America Biologic Medication in COVID-19 Market Share by Type (2017-2028)
9.3 Latin America Biologic Medication in COVID-19 Market Size by Application
9.3.1 Latin America Biologic Medication in COVID-19 Market Size by Application (2017-2022)
9.3.2 Latin America Biologic Medication in COVID-19 Market Size by Application (2023-2028)
9.3.3 Latin America Biologic Medication in COVID-19 Market Share by Application (2017-2028)
9.4 Latin America Biologic Medication in COVID-19 Market Size by Country
9.4.1 Latin America Biologic Medication in COVID-19 Market Size by Country (2017-2022)
9.4.2 Latin America Biologic Medication in COVID-19 Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologic Medication in COVID-19 Market Size (2017-2028)
10.2 Middle East & Africa Biologic Medication in COVID-19 Market Size by Type
10.2.1 Middle East & Africa Biologic Medication in COVID-19 Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Biologic Medication in COVID-19 Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Biologic Medication in COVID-19 Market Share by Type (2017-2028)
10.3 Middle East & Africa Biologic Medication in COVID-19 Market Size by Application
10.3.1 Middle East & Africa Biologic Medication in COVID-19 Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Biologic Medication in COVID-19 Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Biologic Medication in COVID-19 Market Share by Application (2017-2028)
10.4 Middle East & Africa Biologic Medication in COVID-19 Market Size by Country
10.4.1 Middle East & Africa Biologic Medication in COVID-19 Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Biologic Medication in COVID-19 Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Biologic Medication in COVID-19 Introduction
11.1.4 Roche Revenue in Biologic Medication in COVID-19 Business (2017-2022)
11.1.5 Roche Recent Developments
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Biologic Medication in COVID-19 Introduction
11.2.4 Sanofi Revenue in Biologic Medication in COVID-19 Business (2017-2022)
11.2.5 Sanofi Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Biologic Medication in COVID-19 Introduction
11.3.4 Novartis Revenue in Biologic Medication in COVID-19 Business (2017-2022)
11.3.5 Novartis Recent Developments
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Biologic Medication in COVID-19 Introduction
11.4.4 Merck Revenue in Biologic Medication in COVID-19 Business (2017-2022)
11.4.5 Merck Recent Developments
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Biologic Medication in COVID-19 Introduction
11.5.4 Bayer Revenue in Biologic Medication in COVID-19 Business (2017-2022)
11.5.5 Bayer Recent Developments
11.6 Shutaishen
11.6.1 Shutaishen Company Details
11.6.2 Shutaishen Business Overview
11.6.3 Shutaishen Biologic Medication in COVID-19 Introduction
11.6.4 Shutaishen Revenue in Biologic Medication in COVID-19 Business (2017-2022)
11.6.5 Shutaishen Recent Developments
11.7 Biogen
11.7.1 Biogen Company Details
11.7.2 Biogen Business Overview
11.7.3 Biogen Biologic Medication in COVID-19 Introduction
11.7.4 Biogen Revenue in Biologic Medication in COVID-19 Business (2017-2022)
11.7.5 Biogen Recent Developments
11.8 Regeneron Pharmaceuticals
11.8.1 Regeneron Pharmaceuticals Company Details
11.8.2 Regeneron Pharmaceuticals Business Overview
11.8.3 Regeneron Pharmaceuticals Biologic Medication in COVID-19 Introduction
11.8.4 Regeneron Pharmaceuticals Revenue in Biologic Medication in COVID-19 Business (2017-2022)
11.8.5 Regeneron Pharmaceuticals Recent Developments
11.9 Vir Biotech
11.9.1 Vir Biotech Company Details
11.9.2 Vir Biotech Business Overview
11.9.3 Vir Biotech Biologic Medication in COVID-19 Introduction
11.9.4 Vir Biotech Revenue in Biologic Medication in COVID-19 Business (2017-2022)
11.9.5 Vir Biotech Recent Developments
11.10 Junshi Biosciences
11.10.1 Junshi Biosciences Company Details
11.10.2 Junshi Biosciences Business Overview
11.10.3 Junshi Biosciences Biologic Medication in COVID-19 Introduction
11.10.4 Junshi Biosciences Revenue in Biologic Medication in COVID-19 Business (2017-2022)
11.10.5 Junshi Biosciences Recent Developments
11.11 Anke Biotechnology
11.11.1 Anke Biotechnology Company Details
11.11.2 Anke Biotechnology Business Overview
11.11.3 Anke Biotechnology Biologic Medication in COVID-19 Introduction
11.11.4 Anke Biotechnology Revenue in Biologic Medication in COVID-19 Business (2017-2022)
11.11.5 Anke Biotechnology Recent Developments
11.12 OncoImmune
11.12.1 OncoImmune Company Details
11.12.2 OncoImmune Business Overview
11.12.3 OncoImmune Biologic Medication in COVID-19 Introduction
11.12.4 OncoImmune Revenue in Biologic Medication in COVID-19 Business (2017-2022)
11.12.5 OncoImmune Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Biologic Medication in COVID-19 Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Neutralizing Antibodies
Table 3. Key Players of Anti-inflammatory Drugs
Table 4. Global Biologic Medication in COVID-19 Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Biologic Medication in COVID-19 Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Biologic Medication in COVID-19 Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Biologic Medication in COVID-19 Market Share by Region (2017-2022)
Table 8. Global Biologic Medication in COVID-19 Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Biologic Medication in COVID-19 Market Share by Region (2023-2028)
Table 10. Biologic Medication in COVID-19 Market Trends
Table 11. Biologic Medication in COVID-19 Market Drivers
Table 12. Biologic Medication in COVID-19 Market Challenges
Table 13. Biologic Medication in COVID-19 Market Restraints
Table 14. Global Biologic Medication in COVID-19 Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Biologic Medication in COVID-19 Revenue Share by Players (2017-2022)
Table 16. Global Top Biologic Medication in COVID-19 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic Medication in COVID-19 as of 2021)
Table 17. Ranking of Global Top Biologic Medication in COVID-19 Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Biologic Medication in COVID-19 Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Biologic Medication in COVID-19 Product Solution and Service
Table 21. Date of Enter into Biologic Medication in COVID-19 Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Biologic Medication in COVID-19 Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Biologic Medication in COVID-19 Revenue Market Share by Type (2017-2022)
Table 25. Global Biologic Medication in COVID-19 Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Biologic Medication in COVID-19 Revenue Market Share by Type (2023-2028)
Table 27. Global Biologic Medication in COVID-19 Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Biologic Medication in COVID-19 Revenue Share by Application (2017-2022)
Table 29. Global Biologic Medication in COVID-19 Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Biologic Medication in COVID-19 Revenue Share by Application (2023-2028)
Table 31. North America Biologic Medication in COVID-19 Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Biologic Medication in COVID-19 Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Biologic Medication in COVID-19 Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Biologic Medication in COVID-19 Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Biologic Medication in COVID-19 Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Biologic Medication in COVID-19 Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Biologic Medication in COVID-19 Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Biologic Medication in COVID-19 Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Biologic Medication in COVID-19 Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Biologic Medication in COVID-19 Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Biologic Medication in COVID-19 Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Biologic Medication in COVID-19 Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Biologic Medication in COVID-19 Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Biologic Medication in COVID-19 Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Biologic Medication in COVID-19 Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Biologic Medication in COVID-19 Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Biologic Medication in COVID-19 Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Biologic Medication in COVID-19 Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Biologic Medication in COVID-19 Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Biologic Medication in COVID-19 Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Biologic Medication in COVID-19 Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Biologic Medication in COVID-19 Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Biologic Medication in COVID-19 Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Biologic Medication in COVID-19 Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Biologic Medication in COVID-19 Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Biologic Medication in COVID-19 Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Biologic Medication in COVID-19 Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Biologic Medication in COVID-19 Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Biologic Medication in COVID-19 Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Biologic Medication in COVID-19 Market Size by Country (2023-2028) & (US$ Million)
Table 61. Roche Company Details
Table 62. Roche Business Overview
Table 63. Roche Biologic Medication in COVID-19 Product
Table 64. Roche Revenue in Biologic Medication in COVID-19 Business (2017-2022) & (US$ Million)
Table 65. Roche Recent Developments
Table 66. Sanofi Company Details
Table 67. Sanofi Business Overview
Table 68. Sanofi Biologic Medication in COVID-19 Product
Table 69. Sanofi Revenue in Biologic Medication in COVID-19 Business (2017-2022) & (US$ Million)
Table 70. Sanofi Recent Developments
Table 71. Novartis Company Details
Table 72. Novartis Business Overview
Table 73. Novartis Biologic Medication in COVID-19 Product
Table 74. Novartis Revenue in Biologic Medication in COVID-19 Business (2017-2022) & (US$ Million)
Table 75. Novartis Recent Developments
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck Biologic Medication in COVID-19 Product
Table 79. Merck Revenue in Biologic Medication in COVID-19 Business (2017-2022) & (US$ Million)
Table 80. Merck Recent Developments
Table 81. Bayer Company Details
Table 82. Bayer Business Overview
Table 83. Bayer Biologic Medication in COVID-19 Product
Table 84. Bayer Revenue in Biologic Medication in COVID-19 Business (2017-2022) & (US$ Million)
Table 85. Bayer Recent Developments
Table 86. Shutaishen Company Details
Table 87. Shutaishen Business Overview
Table 88. Shutaishen Biologic Medication in COVID-19 Product
Table 89. Shutaishen Revenue in Biologic Medication in COVID-19 Business (2017-2022) & (US$ Million)
Table 90. Shutaishen Recent Developments
Table 91. Biogen Company Details
Table 92. Biogen Business Overview
Table 93. Biogen Biologic Medication in COVID-19 Product
Table 94. Biogen Revenue in Biologic Medication in COVID-19 Business (2017-2022) & (US$ Million)
Table 95. Biogen Recent Developments
Table 96. Regeneron Pharmaceuticals Company Details
Table 97. Regeneron Pharmaceuticals Business Overview
Table 98. Regeneron Pharmaceuticals Biologic Medication in COVID-19 Product
Table 99. Regeneron Pharmaceuticals Revenue in Biologic Medication in COVID-19 Business (2017-2022) & (US$ Million)
Table 100. Regeneron Pharmaceuticals Recent Developments
Table 101. Vir Biotech Company Details
Table 102. Vir Biotech Business Overview
Table 103. Vir Biotech Biologic Medication in COVID-19 Product
Table 104. Vir Biotech Revenue in Biologic Medication in COVID-19 Business (2017-2022) & (US$ Million)
Table 105. Vir Biotech Recent Developments
Table 106. Junshi Biosciences Company Details
Table 107. Junshi Biosciences Business Overview
Table 108. Junshi Biosciences Biologic Medication in COVID-19 Product
Table 109. Junshi Biosciences Revenue in Biologic Medication in COVID-19 Business (2017-2022) & (US$ Million)
Table 110. Junshi Biosciences Recent Developments
Table 111. Anke Biotechnology Company Details
Table 112. Anke Biotechnology Business Overview
Table 113. Anke Biotechnology Biologic Medication in COVID-19 Product
Table 114. Anke Biotechnology Revenue in Biologic Medication in COVID-19 Business (2017-2022) & (US$ Million)
Table 115. Anke Biotechnology Recent Developments
Table 116. OncoImmune Company Details
Table 117. OncoImmune Business Overview
Table 118. OncoImmune Biologic Medication in COVID-19 Product
Table 119. OncoImmune Revenue in Biologic Medication in COVID-19 Business (2017-2022) & (US$ Million)
Table 120. OncoImmune Recent Developments
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biologic Medication in COVID-19 Market Share by Type: 2021 VS 2028
Figure 2. Neutralizing Antibodies Features
Figure 3. Anti-inflammatory Drugs Features
Figure 4. Global Biologic Medication in COVID-19 Market Share by Application: 2021 VS 2028
Figure 5. COVID-19 Case Studies
Figure 6. Influenza Case Studies
Figure 7. Malaria Case Studies
Figure 8. Others Case Studies
Figure 9. Biologic Medication in COVID-19 Report Years Considered
Figure 10. Global Biologic Medication in COVID-19 Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Biologic Medication in COVID-19 Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Biologic Medication in COVID-19 Market Share by Region: 2021 VS 2028
Figure 13. Global Biologic Medication in COVID-19 Market Share by Players in 2021
Figure 14. Global Top Biologic Medication in COVID-19 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic Medication in COVID-19 as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Biologic Medication in COVID-19 Revenue in 2021
Figure 16. North America Biologic Medication in COVID-19 Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Biologic Medication in COVID-19 Market Size Market Share by Type (2017-2028)
Figure 18. North America Biologic Medication in COVID-19 Market Size Market Share by Application (2017-2028)
Figure 19. North America Biologic Medication in COVID-19 Market Size Share by Country (2017-2028)
Figure 20. United States Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Biologic Medication in COVID-19 Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Biologic Medication in COVID-19 Market Size Market Share by Type (2017-2028)
Figure 24. Europe Biologic Medication in COVID-19 Market Size Market Share by Application (2017-2028)
Figure 25. Europe Biologic Medication in COVID-19 Market Size Share by Country (2017-2028)
Figure 26. Germany Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Biologic Medication in COVID-19 Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Biologic Medication in COVID-19 Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Biologic Medication in COVID-19 Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Biologic Medication in COVID-19 Market Size Share by Region (2017-2028)
Figure 36. China Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 42. Latin America Biologic Medication in COVID-19 Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Biologic Medication in COVID-19 Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Biologic Medication in COVID-19 Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Biologic Medication in COVID-19 Market Size Share by Country (2017-2028)
Figure 46. Mexico Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Biologic Medication in COVID-19 Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Biologic Medication in COVID-19 Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Biologic Medication in COVID-19 Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Biologic Medication in COVID-19 Market Size Share by Country (2017-2028)
Figure 52. Turkey Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Biologic Medication in COVID-19 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Roche Revenue Growth Rate in Biologic Medication in COVID-19 Business (2017-2022)
Figure 56. Sanofi Revenue Growth Rate in Biologic Medication in COVID-19 Business (2017-2022)
Figure 57. Novartis Revenue Growth Rate in Biologic Medication in COVID-19 Business (2017-2022)
Figure 58. Merck Revenue Growth Rate in Biologic Medication in COVID-19 Business (2017-2022)
Figure 59. Bayer Revenue Growth Rate in Biologic Medication in COVID-19 Business (2017-2022)
Figure 60. Shutaishen Revenue Growth Rate in Biologic Medication in COVID-19 Business (2017-2022)
Figure 61. Biogen Revenue Growth Rate in Biologic Medication in COVID-19 Business (2017-2022)
Figure 62. Regeneron Pharmaceuticals Revenue Growth Rate in Biologic Medication in COVID-19 Business (2017-2022)
Figure 63. Vir Biotech Revenue Growth Rate in Biologic Medication in COVID-19 Business (2017-2022)
Figure 64. Junshi Biosciences Revenue Growth Rate in Biologic Medication in COVID-19 Business (2017-2022)
Figure 65. Anke Biotechnology Revenue Growth Rate in Biologic Medication in COVID-19 Business (2017-2022)
Figure 66. OncoImmune Revenue Growth Rate in Biologic Medication in COVID-19 Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
